Perioperative Predictors of Early Recurrence for Resectable and Borderline-Resectable Pancreatic Cancer.
carbohydrate antigen 19-9
early recurrence
pancreatic ductal adenocarcinoma
postrecurrence survival
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
11 May 2021
11 May 2021
Historique:
received:
01
04
2021
revised:
30
04
2021
accepted:
06
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
3
6
2021
Statut:
epublish
Résumé
We aimed to identify the perioperative predictors of the early recurrence (ER) of resectable and borderline-resectable pancreatic ductal adenocarcinomas (PDACs). After surgery for a PDAC, most patients develop a recurrence. Predictive factors may therefore guide therapeutic decision-making. Patients (
Identifiants
pubmed: 34064540
pii: cancers13102285
doi: 10.3390/cancers13102285
pmc: PMC8151140
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ann Surg. 2019 Jun;269(6):1154-1162
pubmed: 31082915
J Gastrointest Surg. 2009 Nov;13(11):2050-8
pubmed: 19756875
Cancers (Basel). 2020 Jan 06;12(1):
pubmed: 31935830
Asian Pac J Cancer Prev. 2014;15(15):6015-20
pubmed: 25124566
Nat Rev Cancer. 2011 Apr;11(4):254-67
pubmed: 21390059
Ann Surg Oncol. 2009 Dec;16(12):3316-22
pubmed: 19707831
J Gastrointest Surg. 2009 Oct;13(10):1791-7
pubmed: 19459018
Cancers (Basel). 2020 Oct 14;12(10):
pubmed: 33066393
Clin Gastroenterol Hepatol. 2020 Dec 3;:
pubmed: 33278573
JAMA. 2007 Jan 17;297(3):267-77
pubmed: 17227978
Ann Surg. 2018 Aug;268(2):215-222
pubmed: 29462005
J Gastrointest Surg. 2006 Apr;10(4):511-8
pubmed: 16627216
J Cancer Res Clin Oncol. 2021 May;147(5):1341-1354
pubmed: 33635431
Ann Surg Oncol. 2015 Apr;22(4):1153-9
pubmed: 25358667
Ann Surg. 2020 Apr;271(4):740-747
pubmed: 30312198
Gut Liver. 2014 Jan;8(1):102-8
pubmed: 24516708
Jpn J Clin Oncol. 2015 Sep;45(9):884-91
pubmed: 26142437
Cancer. 2009 Jun 15;115(12):2630-9
pubmed: 19353729
Ann Surg Oncol. 2020 Apr;27(4):1191-1200
pubmed: 31802297
Clin Cancer Res. 2004 Oct 15;10(20):6897-904
pubmed: 15501967
Ann Surg Oncol. 2021 Jan 3;:
pubmed: 33393038
Anticancer Res. 2018 Oct;38(10):5883-5888
pubmed: 30275214
Hepatogastroenterology. 2014 Sep;61(134):1756-61
pubmed: 25436375
Jpn J Clin Oncol. 2019 Feb 1;49(2):190-194
pubmed: 30608598
World J Gastroenterol. 2017 Sep 21;23(35):6420-6428
pubmed: 29085191
Scand J Gastroenterol. 2019 Jan;54(1):95-100
pubmed: 30663442
J Clin Oncol. 2008 Dec 20;26(36):5918-22
pubmed: 19029412
J Surg Oncol. 2012 Jul 1;106(1):111-8
pubmed: 22311829
J Surg Oncol. 2015 Jul;112(1):80-5
pubmed: 26153355
World J Surg. 1997 Feb;21(2):195-200
pubmed: 8995078
Ann Surg Oncol. 2009 May;16(5):1231-40
pubmed: 19263172
J Gastrointest Surg. 2012 May;16(5):977-85
pubmed: 22411488
Cancer Res. 2014 Jun 1;74(11):2913-21
pubmed: 24840647
Ann Surg. 2016 Dec;264(6):1073-1081
pubmed: 26756760
Pancreas. 2018 Jul;47(6):753-758
pubmed: 29771771
Ann Surg. 2018 May;267(5):936-945
pubmed: 28338509
Ann Surg Oncol. 2018 Aug;25(8):2475-2483
pubmed: 29948425
World J Surg Oncol. 2017 Jan 10;15(1):16
pubmed: 28069033
Somatic Cell Genet. 1979 Nov;5(6):957-71
pubmed: 94699
Tumour Biol. 2014 Mar;35(3):2473-80
pubmed: 24218336
Ann Surg Oncol. 2012 Sep;19(9):2917-23
pubmed: 22488099
Lancet. 2016 Jul 16;388(10041):248-57
pubmed: 27265347
Ann Surg. 2018 Sep;268(3):408-420
pubmed: 30080739
In Vivo. 2018 Nov-Dec;32(6):1533-1540
pubmed: 30348713
Oncotarget. 2018 Jan 3;9(11):9789-9807
pubmed: 29515771